Questcor Pharmacueticals (QCOR) Tops Q1 EPS by 10c; Revs Heavy

Questcor Pharmacueticals (NASDAQ: QCOR) reported Q1 EPS of $0.61, $0.10 better than the analyst estimate of $0.51. Revenue for the quarter came in at $96 million versus the consensus estimate of $87.08 million.

For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SAP Q1 results fall short of Wall Street estimates as transformation kicks off
• Equity Lifestyle Properities (ELS) Tops Q1 EPS by 11c, provides guidance
• After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more